Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Early stage nonsmall cell lung cancer: Toward a risk‐adaptive paradigm in the era of biologic precision
AuthorsChaoqi Zhang; Xuanyu Gu; Pan Wang; Dongyu Li; Guochao Zhang; Ting Wang; Peng Wu; Wei Rao; Shan Muhammad; Binghua Tan; Yun Che; Mobai Zhu; Qilin Qiao; Fanbo Lai; Bohui Zhao; Kailun Fei; Yue Wu; Zhihui Zhang; Min Dai; Wanqing Chen; Yawei Zhang; Nan Bi; Jie Wang; Jie He
Affiliations1. Department of Thoracic Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 2. Department of Radiation Oncology The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Zhengzhou China; 3. Department of Pathology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 4. Department of Medicine International College of Medicine and Pharmacy Changsha Medical University Changsha Hunan China; 5. State Key Laboratory of Molecular Oncology Beijing Key Laboratory CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences Beijing China; 6. Department of Clinical Laboratory National Clinical Research Center for Cancer/Cancer Hospital National Cancer Center Chinese Academy of Medical Sciences Peking Union Medical College Beijing China; 7. Department of Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 8. Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 9. Office of Cancer Screening National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 10. Department of Cancer Prevention and Control National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 11. Department of Thoracic Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen China; 12. Department of Thoracic Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Langfang Campus Langfang China; 13. Institute of Cancer Research Henan Academy of Innovations in Medical Sciences Zhengzhou Henan China
The new (version 9) American Joint Committee on Cancer (AJCC) tumor‐node‐metastasis (TNM) staging protocol for carcinoma of the vulva
AuthorsAlexander B. Olawaiye; Elliot A. Asare; Ian S. Hagemann; Priya R. Bhosale; Stephanie Gaillard; Brian Rous; Bunja Rungruang; Shitanshu Uppal; Gulisa Turashvili; Kaled M. Alektiar; Jonathan A. Cosin; Uma Krishnamurti; Lee‐may Chen; Keiichi Fujiwara; Matthew A. Powell; Mauricio A. Cuello; David G. Mutch
Affiliations1. Obstetrics, Gynecology, and Reproductive Sciences University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA; 2. Department of Surgery Huntsman Cancer Institute University of Utah Health Salt Lake City Utah USA; 3. Department of Pathology Washington University St Louis Missouri USA; 4. Department of Radiology The University of Texas MD Anderson Cancer Center Houston Texas USA; 5. Johns Hopkins School of Medicine Baltimore Maryland USA; 6. National Registration and Analysis Service Fulbourn UK; 7. Georgia Regents University Augusta Georgia USA; 8. Department of Obstetrics and Gynecology University of Michigan Ann Arbor Michigan USA; 9. Department of Pathology Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA; 10. Memorial Sloan Kettering Cancer Center New York New York USA; 11. Hartford Healthcare Cancer Institute University of Connecticut New Britain Connecticut USA; 12. Yale University New Haven Connecticut USA; 13. Helen Diller Family Comprehensive Cancer Center University of California–San Francisco San Francisco California USA; 14. Saitama Medical University International Medical Center Hidaka Saitama Japan; 15. Obstetrics and Gynecology Washington University St Louis Missouri USA; 16. Pontificia Universidad Católica de Chile Santiago Santiago Metropolitan Region Chile
Discordant molecular biomarkers in unfavorable intermediate‐risk localized prostate cancer
AuthorsMichael Rooney; Krishnan R. Patel; Shalin Shah; Justin R. Gregg; Steven Jay Frank; Karen Hoffman; Ryan Park; Comron J. Hassanzadeh; Seungtaek Choi; Sean McGuire; Quynh‐Nhu Nguyen; Daniel N. Costa; Patricia Troncoso; Sumit K. Subudhi; Shuang George Zhao; Curtis A. Pettaway; Paul Corn; Chad Tang; Phuoc T. Tran
Affiliations1. Division of Radiation Oncology Department of Genitourinary Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA; 2. Division of Surgery Department of Urology The University of Texas MD Anderson Cancer Center Houston Texas USA; 3. Division of Diagnostic Imaging The University of Texas MD Anderson Cancer Center Houston Texas USA; 4. Division of Pathology and Laboratory Medicine Department of Pathology–Anatomical The University of Texas MD Anderson Cancer Center Houston Texas USA; 5. Division of Cancer Medicine Department of Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA; 6. Department of Human Oncology University of Wisconsin Madison Wisconsin USA
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries
AuthorsHyuna Sung; Adalberto M. Filho; Mathieu Laversanne; Jacques Ferlay; Rebecca L. Siegel; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Affiliations1. Surveillance, Prevention, and Health Services Research American Cancer Society Atlanta Georgia USA; 2. Cancer Surveillance Branch International Agency for Research on Cancer Lyon France
Serious mental illness and cancer: A call to action for equitable care
AuthorsDaniel McFarland; Cristiane Bergerot; Pernille Bidstrup; Miri Cohen; Paul D’Alton; Shahrzad Zamani; Louise Mullen; Michelle Riba; Luigi Grassi; Kelly Irwin
Affiliations1. Department of Psychiatry University of Rochester Medical Center Rochester New York USA; 2. Wilmot Cancer Center University of Rochester Medical Center Rochester New York USA; 3. Oncoclinicas and Co‐Medica Scientia Innovation Research (MEDSIR) Sao Paulo Brazil; 4. Danish Cancer Institute Copenhagen Denmark; 5. School of Social Work University of Haifa Haifa Israel; 6. School of Psychology University College Dublin Dublin Ireland; 7. Florida State University Tallahassee Florida USA; 8. National Cancer Control Program Dublin Ireland; 9. Department of Psychiatry Rogel Cancer Center University of Michigan Ann Arbor Michigan USA; 10. Department of Neuroscience and Rehabilitation University of Ferrara Ferrara Italy; 11. Department of Psychiatry Massachusetts General Hospital Boston Massachusetts USA
Extranodal natural killer/T‐cell lymphoma: From fatal to curable
AuthorsJie Xiong; Yok‐Lam Kwong; Laurence de Leval; Shu‐Nan Qi; Choon Kiat Ong; Philippe Gaulard; Arnaud Jaccard; Steven M. Horwitz; Ye‐Xiong Li; Sai‐Juan Chen; Ritsuro Suzuki; Won Seog Kim; Wei‐Li Zhao
Affiliations1. Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China; 2. Department of Medicine University of Hong Kong Queen Mary Hospital Hong Kong China; 3. Department of Laboratory Medicine and Pathology Institute of Pathology Lausanne University Hospital and Lausanne University Lausanne Switzerland; 4. Department of Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 5. Lymphoma Translational Research Laboratory, Division of Cellular and Molecular Research National Cancer Center Singapore Singapore; 6. Cancer and Stem Cell Biology Program Duke‐National University of Singapore Medical School Singapore; 7. Center of Excellence in Translational Medicine Fundeni Clinical Institute Bucharest Romania; 8. Department of Pathology Henri Mondor Hospital, Public Assistance–Hospital of Paris INSERM Unit 955 Mondor Institute for Biomedical Research and Paris Est Creteil University Creteil France; 9. Department of Hematology and Cellular Therapy University Hospital of Limoges Limoges France; 10. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA; 11. Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine Shimane University Izumo Japan; 12. Division of Hematology‐Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Korea; 13. Laboratory of Molecular Pathology Sino‐French Center of Competence in Research in Life Sciences and Genomics Shanghai China
Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma
AuthorsKevin Card; Rizwan Haq; John Mignano; Shilpa J. Desai
Affiliations1. Retina and Macular Disease Service New England Eye Center Boston Massachusetts USA; 2. Department of Ophthalmology Tufts University Medical Center Boston Massachusetts USA; 3. Department of Hematology and Oncology Dana Farber Cancer Institute Boston Boston Massachusetts USA; 4. Department of Radiation Oncology Tufts University Medical Center Boston Massachusetts USA
Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates
AuthorsXia Wu; Heather Landau; Jennifer E. Liu; Yihan Cao; Raymond L. Comenzo
Affiliations1. Tufts Medicine Myeloma and Amyloid Program Tufts Medical Center Boston Massachusetts USA; 2. Department of Medicine Massachusetts General Hospital Boston Massachusetts USA; 3. Adult Bone Marrow Transplantation Service Memorial Sloan Kettering Cancer Center New York New York USA; 4. Cardiology Service Department of Internal Medicine Memorial Sloan Kettering Cancer Center New York New York USA; 5. Department of Radiology Massachusetts General Hospital Boston Massachusetts USA; 6. Division of Hematology Oncology Tufts Medical Center Boston Massachusetts USA
Colorectal cancer screening: An update to the American Cancer Society guideline, 2026
AuthorsAndrew M. D. Wolf; Richard M. Hoffman; Louise C. Walter; Charnita Zeigler‐Johnson; Timothy R. Church; Carmen E. Guerra; Elena B. Elkin; Ruth Etzioni; Abbe Herzig; Kevin C. Oeffinger; Rebecca B. Perkins; Sana Raoof; Ya‐Chen Tina Shih; Steven J. Skates; Tyler B. Kratzer; Deana Manassaram‐Baptiste; Robert A. Smith
Affiliations1. University of Virginia School of Medicine Charlottesville Virginia USA; 2. University of Iowa Carver College of Medicine Iowa City Iowa USA; 3. University of California, San Francisco and the San Francisco Veterans Affairs Health Care System San Francisco California USA; 4. Cancer Prevention and Control Fox Chase Cancer Center Philadelphia Pennsylvania USA; 5. University of Minnesota School of Public Health Minneapolis Minnesota USA; 6. Biostatistics and Epidemiology University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA; 7. Columbia University New York New York USA; 8. Fred Hutchinson Cancer Center Seattle Washington USA; 9. Sarah Lawrence College Bronxville New York USA; 10. DCI Center for Onco‐Primary Care Duke University Durham North Carolina USA; 11. Tufts University and Tufts Medical Center Boston Massachusetts USA; 12. Brown University Health Providence Rhode Island USA; 13. Department of Radiation Oncology David Geffen Schoold of Medicine, and Director of Cancer Health Economics Research Program University of California Los Angeles California USA; 14. Biostatistics Massachusetts General Hospital Boston Massachusetts USA; 15. Surveillance, Prevention, and Health Services Research Department American Cancer Society Atlanta Georgia USA; 16. Center for Early Cancer Detection American Cancer Society Atlanta Georgia USA
Twenty‐year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I–III breast cancer
AuthorsOrit Kaidar‐Person; Caroline G. Weltens; Catherine Fortpied; Luc J. E. E. Scheijmans; Carine Y. Kirkove; Volker Budach; Karine Peignaux‐Casasnovas; Mariacarla Valli; Max Peters; Femke van der Leij; Sofia Rivera; Nicola Weidner; Desirée H. J. G. van den Bongard; Claudia Linsenmeier; Roxolyana Abdah‐Bortnyak; Shaymaa Hosni; Eveline Koiter; Antoine M. Engelen; Adinda Baten; Lydia Champezou; Alain Fourquet; Harry G. M. M. Bartelink; Henk Struikmans; Philip M. P. Poortmans; for the European Organization for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups
Affiliations1. Breast Radiation Unit Sheba Medical Center Ramat Gan Israel; 2. Gray Faculty of Medical and Health Sciences Tel Aviv University Tel Aviv Israel; 3. Department of Radiation Oncology University Hospitals Leuven Leuven Belgium; 4. Laboratory of Experimental Radiation Oncology Katholieke Universiteit te Leuven Leuven Belgium; 5. European Organization for Research and Treatment of Cancer Brussels Belgium; 6. Department of Radiation Oncology Institute Verbeeten Tilburg Netherlands; 7. Department of Radiation Oncology University Hospital Saint Luc Université Catholique de Louvain Brussels Belgium; 8. Department of Radiation Oncology Comprehensive Cancer Center Charite–University Medicine Berlin Corporate Member of Free University of Berlin and Humboldt University of Berlin BE Berlin Germany; 9. Radiation Oncology Vosspalais BE Berlin Germany; 10. Department of Radiation Oncology Centre Georges François Leclerc Dijon France; 11. Department of Radiation Oncology Sant Anna Hospital Como Italy; 12. Department of Radiation Oncology Ospedale Valduce Como Italy; 13. Department of Radiation Oncology Radiotherapiegroep Deventer/Arnhem Netherlands; 14. Department of Radiation Oncology University Medical Centre Utrecht Utrecht Netherlands; 15. Department of Radiation Oncology Gustave Roussy Cancer Centre Villejuif France; 16. Department of Radiation Oncology University Hospital Tübingen Germany; 17. Department of Radiation Oncology Cancer Center Amsterdam Amsterdam University Medical Center University of Amsterdam Amsterdam Netherlands; 18. Department of Radiation Oncology University Hospital Zürich University of Zürich Zürich Switzerland; 19. Department of Radiation Oncology The Joseph Fishman Oncology Center Rambam Health Care Campus Haifa Israel; 20. Nottingham University Hospitals National Health Service Trust Nottingham UK; 21. Department of Radiation Oncology Medisch Spectrum Twente Enschede Netherlands; 22. Department of Radiation Oncology Institut Curie Paris France; 23. Department of Radiation Oncology Netherlands Cancer Institute Amsterdam Netherlands; 24. Department of Radiation Oncology Haaglanden Medical Center the Hague Leidschendam Netherlands; 25. Department of Radiation Oncology Iridium Netwerk Wilrijk‐Antwerp Belgium; 26. Faculty of Medicine and Health Sciences University of Antwerp Wilrijk‐Antwerp Belgium
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
